ACHV Stock Summary and Trading Ideas (Achieve Life Sciences - Common Shares | NASDAQ:ACHV)

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Achieve Life Sciences - Common Shares trades on the NASDAQ stock market under the symbol ACHV.

As of January 14, 2025, ACHV stock price declined to $3.15 with 176,487 million shares trading.

ACHV has a beta of 1.17, meaning it tends to be more sensitive to market movements. ACHV has a correlation of 0.13 to the broad based SPY ETF.

ACHV has a market cap of $108.33 million. This is considered a Micro Cap stock.

In the last 3 years, ACHV traded as high as $10.30 and as low as $2.00.

The top ETF exchange traded funds that ACHV belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.

ACHV has underperformed the market in the last year with a price return of -26.6% while the SPY ETF gained +23.6%. ACHV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.0% and -12.7%, respectively, while the SPY returned +0.8% and -1.0%, respectively.

ACHV support price is $3.18 and resistance is $3.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHV shares will trade within this expected range on the day.